Yannick Degboé

ORCID: 0000-0002-4293-8596
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Bone health and treatments
  • Bone health and osteoporosis research
  • Mast cells and histamine
  • Bone and Joint Diseases
  • Bone Metabolism and Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Cytokine Signaling Pathways and Interactions
  • Cell Adhesion Molecules Research
  • Urticaria and Related Conditions
  • Monoclonal and Polyclonal Antibodies Research
  • Immunotherapy and Immune Responses
  • Systemic Sclerosis and Related Diseases
  • melanin and skin pigmentation
  • Asthma and respiratory diseases
  • Dermatological and Skeletal Disorders
  • Chronic Lymphocytic Leukemia Research
  • Immune Cell Function and Interaction
  • Food Allergy and Anaphylaxis Research
  • RNA Research and Splicing
  • Immune cells in cancer
  • Heterotopic Ossification and Related Conditions

Université de Toulouse
2017-2025

Centre Hospitalier Universitaire de Toulouse
2009-2025

Inserm
2013-2025

Université Toulouse III - Paul Sabatier
2013-2024

Hôpital Purpan
2011-2024

Centre National de la Recherche Scientifique
2013-2024

Hôpital Paule de Viguier
2016-2024

French Clinical Research Infrastructure Network
2024

Lancaster University
2023

Hôpital de La Grave
2014-2022

Macrophages contribute to the pathogenesis of rheumatoid arthritis (RA). They can display different states activation or “polarization”, notably so-called inflammatory “M1” and various alternative “M2” polarizations, characterized by distinct functions. Data regarding effects RA anti-cytokine biological disease-modifying anti-rheumatic drugs (bDMARDs) on macrophage polarization are scarce. We aimed assess in vitro modulation bDMARDs targeting pro-inflammatory cytokines RA. generated monocyte...

10.3389/fimmu.2019.00003 article EN cc-by Frontiers in Immunology 2019-01-18

Dear Editor, Beck et al. [1] recently identified a genetic disorder that connects seemingly unrelated adult-onset inflammatory syndromes as VEXAS syndrome. We report case of syndrome in patient with previous SpA favourable response to i.v. immunoglobulin and anti-IL17 therapy. In 2010, diagnosis was made 57-year-old man, who had back pain, peripheral arthritis, bilateral active sacroiliitis on MRI (Fig. 1A) HLA- B27–positive testing [2]. After failure several NSAIDs, the initiation anti-TNF...

10.1093/rheumatology/keab211 article EN Lara D. Veeken 2021-03-09

In the stressful context of coronavirus disease 2019 (COVID-19) pandemic, some reports have raised concerns regarding psychiatric disorders with use hydroxychloroquine. this study, we reviewed all adverse effects hydroxychloroquine in COVID-19 patients, as well other indications, reported VigiBase, World Health Organization's (WHO) global database individual case safety reports. First, analyzed effects, including suicide, patients to 16 June 2020. We also performed disproportionality...

10.1007/s40264-020-01013-3 article EN other-oa Drug Safety 2020-10-19

Introduction: Adipose-derived mesenchymal stem cells (ADSC) have been shown to remarkable immune-modulating effects. However, their efficacy in clinical trials has yet be fully demonstrated. This could due a lack of proper inflammatory environment vivo that primes ADSC. Here, we define how the articular microenvironment rheumatoid arthritis (RA) patients modulates therapeutic efficiency Methods: Synovial fluids (SF) were collected from 8 RA patients, 2 Spondyloarthritis and one control...

10.3389/fimmu.2019.01482 article EN cc-by Frontiers in Immunology 2019-06-28

10.1016/j.rhum.2025.01.023 article CS Revue du Rhumatisme 2025-02-01

To search for association between ultrasound (US) enthesis abnormalities and disease activity, spine sacro-iliac joints (SIJ) MRI inflammatory lesions structural changes in a cohort of patients suspected axial spondyloarthritis (SpA).Patients: Of 708 included the DESIR(Devenir des Spondyloarthrites Indifférenciées Récentes) cohort, 402 had an US assessment were selected this study. Imaging: Achilles, lateral epicondyles, superior patellar ligament, inferior ligament entheses systematically...

10.1136/rmdopen-2017-000482 article EN cc-by-nc RMD Open 2017-09-01

Abstract Introduction Our objective was to assess the capacity of dendrimer aza-bis-phosphonate (ABP) modulate phenotype monocytes (Mo) and derived dendritic cells (MoDC) activated in response toll-like receptor 4 (TLR4) interferon γ (IFN- γ) stimulation. Methods Mo ( n = 12) MoDC 11) from peripheral blood healthy donors were prepared. Cells preincubated or not for 1 hour with ABP, then incubated lipopolysaccharide (LPS; as a TLR4 ligand) (IFN-γ) 38 hours. Secretion tumor necrosis factor α...

10.1186/ar4546 article EN cc-by Arthritis Research & Therapy 2014-04-18

Objectives We compared the ability of antibodies against cyclic citrullinated peptides (anti-CCP2), mutated vimentin (anti-MCV) and fibrinogen (AhFibA) to predict 1 year rapid radiographic progression (RRP; total Sharp score variation ≥5 points), in early rheumatoid arthritis (RA). Methods analysed 566 patients from ESPOIR cohort with RA fulfilling 2010 American College Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria at 1. assayed 3 anticitrullinated peptide (ACPA) tests...

10.1136/rmdopen-2015-000180 article EN cc-by-nc RMD Open 2015-11-01

Objectives To compare the risk of serious adverse events, infections and death caused by methotrexate biological disease-modifying antirheumatic drug (bDMARD) combination therapy versus a bDMARD prescribed as monotherapy in rheumatoid arthritis (RA). Methods A systematic literature review was conducted until February 2016 PubMed, Embase Cochrane Library databases selecting randomised controlled trials comparing to RA. The meta-analysis compared occurrence (1) (2) (3) among these groups...

10.1136/rmdopen-2016-000352 article EN cc-by-nc RMD Open 2017-02-01
Coming Soon ...